As none of the 57 DUX4-target genes used in our study to calculate the DUX4 signature was included in the FSHD lymphoblast score, we do not expect this cell population to affect our DUX4 signature detection. The gene discussed is DUX4; the disease is Facioscapulohumeral dystrophy.